-
1
-
-
0028896166
-
Camptothecin and taxol: Discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture
-
Wall ME, Wani MC. Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 1995; 55(4): 753-60.
-
(1995)
Cancer Res
, vol.55
, Issue.4
, pp. 753-760
-
-
Wall, M.E.1
Wani, M.C.2
-
2
-
-
0022340594
-
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
-
Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985; 260(27): 14873-8.
-
(1985)
J Biol Chem
, vol.260
, Issue.27
, pp. 14873-14878
-
-
Hsiang, Y.H.1
Hertzberg, R.2
Hecht, S.3
Liu, L.F.4
-
3
-
-
0032871803
-
Structural insights into the function of type IB topoisomerases
-
Redinbo MR, Champoux JJ, Hol WG. Structural insights into the function of type IB topoisomerases. Curr Opin Struct Biol 1999; 9(1): 29-36.
-
(1999)
Curr Opin Struct Biol
, vol.9
, Issue.1
, pp. 29-36
-
-
Redinbo, M.R.1
Champoux, J.J.2
Hol, W.G.3
-
4
-
-
0038167666
-
The camptothecins
-
Pizzolato JF, Saltz LB. The camptothecins. Lancet. 2003; 361(9376): 2235-42.
-
(2003)
Lancet.
, vol.361
, Issue.9376
, pp. 2235-2242
-
-
Pizzolato, J.F.1
Saltz, L.B.2
-
5
-
-
33749034730
-
Topoisomerase I inhibitors: Camptothecins and beyond
-
Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006; 6(10): 789-802.
-
(2006)
Nat Rev Cancer
, vol.6
, Issue.10
, pp. 789-802
-
-
Pommier, Y.1
-
6
-
-
30644464675
-
Pharmacogenetics of irinotecan metabolism and transport: An update
-
Smith NF, Figg WD, Sparreboom A. Pharmacogenetics of irinotecan metabolism and transport: an update. Toxicol In vitro 2006; 20(2): 163-75.
-
(2006)
Toxicol In vitro
, vol.20
, Issue.2
, pp. 163-175
-
-
Smith, N.F.1
Figg, W.D.2
Sparreboom, A.3
-
7
-
-
0037238805
-
Lessons learned from the irinotecan metabolic pathway
-
Ma MK, McLeod HL. Lessons learned from the irinotecan metabolic pathway. Curr Med Chem 2003; 10(1): 41-9.
-
(2003)
Curr Med Chem
, vol.10
, Issue.1
, pp. 41-49
-
-
Ma, M.K.1
McLeod, H.L.2
-
8
-
-
0034892379
-
Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11)
-
Mathijssen RHJ, van Alphen RJ, Verweij J, et al. Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11). Clin Cancer Res 2001; 7(8): 2182-94.
-
(2001)
Clin Cancer Res
, vol.7
, Issue.8
, pp. 2182-2194
-
-
Mathijssen, R.H.J.1
van Alphen, R.J.2
Verweij, J.3
-
9
-
-
34247618754
-
Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDPglucuronosyltransferase 2B7
-
Miley MJ, Zielinska AK, Keenan JE, Bratton SM, Radominska-Pandya A, Redinbo MR. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDPglucuronosyltransferase 2B7. J Mol Biol 2007; 369(2): 498-511.
-
(2007)
J Mol Biol
, vol.369
, Issue.2
, pp. 498-511
-
-
Miley, M.J.1
Zielinska, A.K.2
Keenan, J.E.3
Bratton, S.M.4
Radominska-Pandya, A.5
Redinbo, M.R.6
-
10
-
-
33746780621
-
Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan
-
Nagar S, Blanchard RL. Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab Rev 2006; 38(3): 393-409.
-
(2006)
Drug Metab Rev
, vol.38
, Issue.3
, pp. 393-409
-
-
Nagar, S.1
Blanchard, R.L.2
-
11
-
-
77953395957
-
Review: Chemotherapy-induced diarrhea: Pathophysiology, frequency and guideline-based management
-
Stein A, Voigt W, Jordan K. Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol 2010; 2: 51-63.
-
(2010)
Ther Adv Med Oncol
, vol.2
, pp. 51-63
-
-
Stein, A.1
Voigt, W.2
Jordan, K.3
-
12
-
-
2642521486
-
The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours
-
Tobin PJ, Dodds HM, Clarke S, Schnitzler M, Rivory LP. The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours. Oncol rep 2003; 10(6): 1977-9.
-
(2003)
Oncol rep
, vol.10
, Issue.6
, pp. 1977-1979
-
-
Tobin, P.J.1
Dodds, H.M.2
Clarke, S.3
Schnitzler, M.4
Rivory, L.P.5
-
13
-
-
33749068024
-
St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal proinflammatory cytokines and inhibition of intestinal epithelial apoptosis
-
Hu ZP, Yang XX, Chan SY, et al. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal proinflammatory cytokines and inhibition of intestinal epithelial apoptosis. Toxicol Appl Pharmacol 2006; 216(2): 225-37.
-
(2006)
Toxicol Appl Pharmacol
, vol.216
, Issue.2
, pp. 225-237
-
-
Hu, Z.P.1
Yang, X.X.2
Chan, S.Y.3
-
14
-
-
78651061453
-
Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen
-
Kurita A, Kado S, Matsumoto T, et al. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen. Cancer Chemother Pharmacol 2011; 67(1): 201-13.
-
(2011)
Cancer Chemother Pharmacol
, vol.67
, Issue.1
, pp. 201-213
-
-
Kurita, A.1
Kado, S.2
Matsumoto, T.3
-
15
-
-
37049006270
-
Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma
-
Flieger D, Klassert C, Hainke S, Keller R, Kleinschmidt R, Fischbach W. Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma. Oncology 2007; 72(1-2): 10-6.
-
(2007)
Oncology
, vol.72
, Issue.1-2
, pp. 10-16
-
-
Flieger, D.1
Klassert, C.2
Hainke, S.3
Keller, R.4
Kleinschmidt, R.5
Fischbach, W.6
-
16
-
-
0031262639
-
Role of intestinal bacteria in nutrient metabolism
-
Cummings JH, Macfarlane GT. Role of intestinal bacteria in nutrient metabolism. J Parenter Enteral Nutr 1997; 21(6): 357-65.
-
(1997)
J Parenter Enteral Nutr
, vol.21
, Issue.6
, pp. 357-365
-
-
Cummings, J.H.1
McFarlane, G.T.2
-
17
-
-
0037425743
-
Gut flora in health and disease
-
Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-9.
-
(2003)
Lancet
, vol.361
, pp. 512-519
-
-
Guarner, F.1
Malagelada, J.R.2
-
18
-
-
77951026738
-
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)
-
Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31(5): 431-55.
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, Issue.5
, pp. 431-455
-
-
Cohen, S.H.1
Gerding, D.N.2
Johnson, S.3
-
19
-
-
10944272743
-
Antibacterial resistance worldwide: Causes, challenges and responses
-
Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004; 10(12 Suppl): S122-9.
-
(2004)
Nat Med
, vol.10
, Issue.12 SUPPL
-
-
Levy, S.B.1
Marshall, B.2
-
20
-
-
0021337428
-
Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections
-
Nord CE, Kager L, Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 1984; 76(5A): 99-106.
-
(1984)
Am J Med
, vol.76
, Issue.5 A
, pp. 99-106
-
-
Nord, C.E.1
Kager, L.2
Heimdahl, A.3
-
21
-
-
0032730770
-
Irinotecan (CPT-11) induced colitis: Report of a case and review of Food and Drug Administration MEDWATCH reporting
-
Sears S, McNally P, Bachinski MS, Avery R. Irinotecan (CPT-11) induced colitis: report of a case and review of Food and Drug Administration MEDWATCH reporting. Gastrointest Endosc 1999; 50(6): 841-4.
-
(1999)
Gastrointest Endosc
, vol.50
, Issue.6
, pp. 841-844
-
-
Sears, S.1
McNally, P.2
Bachinski, M.S.3
Avery, R.4
-
22
-
-
0029823366
-
Review article: Antibiotic-induced Clostridium difficile infection
-
Settle CD, Wilcox MH. Review article: antibiotic-induced Clostridium difficile infection. Alim Pharmacol Ther 1996; 10(6): 835-41.
-
(1996)
Alim Pharmacol Ther
, vol.10
, Issue.6
, pp. 835-841
-
-
Settle, C.D.1
Wilcox, M.H.2
-
23
-
-
3342986585
-
Antibiotic therapy may induce cancers in the colon and breasts through a mechanism involving bile acids and colonic bacteria
-
Stamp D. Antibiotic therapy may induce cancers in the colon and breasts through a mechanism involving bile acids and colonic bacteria. Med Hypotheses 2004; 63(3): 555-6.
-
(2004)
Med Hypotheses
, vol.63
, Issue.3
, pp. 555-556
-
-
Stamp, D.1
-
24
-
-
33751361302
-
Bacteria, inflammation, and colon cancer
-
Yang L, Pei Z. Bacteria, inflammation, and colon cancer. World J Gastroenterol 2006; 12(42): 6741-6.
-
(2006)
World J Gastroenterol
, vol.12
, Issue.42
, pp. 6741-6746
-
-
Yang, L.1
Pei, Z.2
-
26
-
-
0036135758
-
Hydrolysis of 4-methylumbelliferyl-beta-D-glucuronide in differing sample fractions of river waters and its implication for the detection of fecal pollution
-
Farnleitner AH, Hocke L, Beiwl C, Kavka GC, Mach RL. Hydrolysis of 4-methylumbelliferyl-beta-D-glucuronide in differing sample fractions of river waters and its implication for the detection of fecal pollution. Water Res 2002; 36: 975-81.
-
(2002)
Water Res
, vol.36
, pp. 975-981
-
-
Farnleitner, A.H.1
Hocke, L.2
Beiwl, C.3
Kavka, G.C.4
Mach, R.L.5
-
27
-
-
3843135145
-
Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats
-
Fittkau M, Voigt W, Holzhausen H-J, rgen, Schmoll H-J. Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats. J Cancer Res Clin Oncol 2004; 130: 388-94.
-
(2004)
J Cancer Res Clin Oncol
, vol.130
, pp. 388-394
-
-
Fittkau, M.1
Voigt, W.2
Holzhausen, H.-J.3
Rgen4
Schmoll, H.-J.5
-
28
-
-
0035287418
-
Identification and cloning of gusA, encoding a new beta-glucuronidase from Lactobacillus gasseri ADH
-
Russell WM, Klaenhammer TR. Identification and cloning of gusA, encoding a new beta-glucuronidase from Lactobacillus gasseri ADH. Appl Environ Microbiol 2001; 67(3): 1253-61.
-
(2001)
Appl Environ Microbiol
, vol.67
, Issue.3
, pp. 1253-1261
-
-
Russell, W.M.1
Klaenhammer, T.R.2
-
29
-
-
78149295964
-
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme
-
Wallace BD, Wang H, Lane KT, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010; 330(6005): 831-5.
-
(2010)
Science
, vol.330
, Issue.6005
, pp. 831-835
-
-
Wallace, B.D.1
Wang, H.2
Lane, K.T.3
-
30
-
-
0033003760
-
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays
-
Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 1999; 4(2): 67-73.
-
(1999)
J Biomol Screen
, vol.4
, Issue.2
, pp. 67-73
-
-
Zhang, J.H.1
Chung, T.D.2
Oldenburg, K.R.3
-
31
-
-
0015368548
-
A new potent-glucuronidase inhibitor, D-glucaro--lactam derived from nojirimycin
-
Niwa T, Tsuruoka T, Inoue S, Naito Y, Koeda T. A new potent-glucuronidase inhibitor, D-glucaro--lactam derived from nojirimycin. J Biochem 1972; 72(1): 207-11.
-
(1972)
J Biochem
, vol.72
, Issue.1
, pp. 207-211
-
-
Niwa, T.1
Tsuruoka, T.2
Inoue, S.3
Naito, Y.4
Koeda, T.5
-
32
-
-
34249000046
-
A high-throughput screen for aggregation-based inhibition in a large compound library
-
Feng BY, Simeonov A, Jadhav A, Babaoglu K, Inglese J, Shoichet BK, et al. A high-throughput screen for aggregation-based inhibition in a large compound library. J Med Chem 2007; 50(10): 2385-90.
-
(2007)
J Med Chem
, vol.50
, Issue.10
, pp. 2385-2390
-
-
Feng, B.Y.1
Simeonov, A.2
Jadhav, A.3
Babaoglu, K.4
Inglese, J.5
Shoichet, B.K.6
-
33
-
-
0037061628
-
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
-
McGovern SL, Caselli E, Grigorieff N, Shoichet BK. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002; 45(8): 1712-22.
-
(2002)
J Med Chem
, vol.45
, Issue.8
, pp. 1712-1722
-
-
McGovern, S.L.1
Caselli, E.2
Grigorieff, N.3
Shoichet, B.K.4
|